Publications by authors named "Jacob Bitran"

Claim this Profile
N
Nivolumab-Induced Hemophagocytic Lymphohistiocytosis (HLH) in a Patient With Metastatic Melanoma: A Case Report and Literature Review.
Ravjot K Virdi, Umar Hussain, Jacob Bitran

Cureus· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide Trends and Disparities in End-of-Life Care for Acute Myeloid Leukemia: A 2019-2021 NIS Analysis of Palliative Care Utilization and Hospitalization Costs.
Nandhini Iyer, Krishna Doshi, Sripada Preetham Kasire, Sandeep Guntuku, Jacob Bitran

Am J Hosp Palliat Care· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Therapy of Adult Patients with Acute Lymphoblastic Leukemia.
Oscar Sucre, Saagar Pamulapati, Zeeshan Muzammil, Jacob Bitran

Cells· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-Cell Lymphoproliferative Disorders Following Allogeneic Bone Marrow Transplant: A Report of Two Cases and a Literature Review.
Nicholas Prabhakar, Harrah Chiang, Irma Munoz Verdugo, Ari Hakimian, Shams Bufalino, Jacob Bitran

Cureus· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Recurrent Multiple Myeloma as Testicular Plasmacytoma Without Systemic Disease.
Krishna Doshi, Sabree Abedrabo, Jacob Bitran, Nahren Asado

Cureus· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study.
John Kuruvilla, Philippe Armand, Mehdi Hamadani, Justin Kline, Craig H Moskowitz, Jacob Bitran

Leuk Lymphoma· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mantle Zone Lymphoma With Prostate Gland Enlargement: A Case Report.
Krishna Doshi, Anjana Chandran, Yanxia Li, Jacob Bitran

Cureus· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of the Abscopal Effect in the Era of Immunotherapy.
Edward Nabrinsky, Jason Macklis, Jacob Bitran

Cureus· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary AL amyloidosis: A review and update on treatment options.
Lindsay N Moy, Mahum Mirza, Blake Moskal, Nahren Asado, Bhaven Shah, Jacob Bitran

Ann Med Surg (Lond)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination regimen.
David Daniely, Eli Forouzan, Tanya M Spektor, Alexa Cohen, Jacob D Bitran

Exp Hematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin Light Chain (AL) Amyloidosis Preceding Marginal Zone Lymphoma: A Case Report.
Krishna Doshi, Jacob Bitran, Brian Adley, Nahren Asado

Cureus· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Central Nervous System Lymphoma With Systemic Recurrence.
Sasirekha Pandravada, Phillip Knouse, Jacob Bitran

Cureus· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-Related Acute Myeloid Leukemia Following TCHP Chemotherapy in Two HER2+ Breast Cancer Patients.
Navroop Gill, Anjana Chandran, Brian Adley, Jacob Bitran

Cureus· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DA-REPOCH Versus R-CHOP for the Treatment of Activated B-Cell Subtype Diffuse Large B-Cell Lymphoma: A Community Center Experience.
Phillip Knouse, Edward Nabrinsky, Ronald L Sirota, David Hakimian, Jacob Bitran

Cureus· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing Unwarranted Oncology Care Variation Across a Clinically Integrated Network: A Collaborative Physician Engagement Strategy.
Jon M Richards, Trever B Burgon, Diana Tamondong-Lachica, Jacob D Bitran, Wilfredo L Liangco

J Oncol Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Abscopal Effect Exists in Non-small Cell Lung Cancer: A Case Report and Review of the Literature.
Jacob Bitran

Cureus· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Study of Double-hit Lymphomas in Elderly Patients (Aged > 70 Years): Overall Outcomes.
Christie Hancock, Phillip Knouse, Imad Almanaseer, Jacob Bitran

Clin Lymphoma Myeloma Leuk· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment.
Aleksandra P Vidisheva, James Wang, Tanya M Spektor, Jacob D Bitran, Jose Lutzky

Support Care Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of sorafenib in overcoming resistance of chemotherapy-failure castration-resistant prostate cancer.
Andrew Meyer, Peter Cygan, Kathy Tolzien, Angel G Galvez, Jacob D Bitran

Clin Genitourin Cancer· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration - resistant prostate cancer patients responding to chemotherapy.
Chadi Nabhan, Andrew Meyer, Kathy Tolzien, Jacob D Bitran, Timothy M Lestingi

Avicenna J Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients.
Chadi Nabhan, Nancy Davis, Jacob D Bitran, Angel Galvez, Walter Fried

Cancer· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disclosing the cancer diagnosis:the myth and the truth.
Chadi Nabhan, Jacob D Bitran, Clint Moore

J Clin Oncol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
Hillard M Lazarus, Mei-Jie Zhang, Jeanette Carreras, Brandon M Hayes-Lattin, Asli Selmin Ataergin, Jacob D Bitran

Biol Blood Marrow Transplant· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib has moderate single-agent activity in chemotherapy-naïve castration-resistant prostate cancer: final results of a phase II trial.
Chadi Nabhan, Timothy M Lestingi, Angel Galvez, Kathy Tolzien, Susan K Kelby, Jacob D Bitran

Urology· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, Fausto R Loberiza, James O Armitage, Jacob D Bitran

Biol Blood Marrow Transplant· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis